HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10
HTG Molecular Diagnostics (Nasdaq: HTGM) announced it will report its Q3 financial results on November 10, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (Nasdaq: HTGM) announced it will report its Q3 financial results on November 10, 2021, after market close. Management will hold a conference call at 4:30 pm ET to discuss the results and provide a corporate update. HTG is focused on advancing precision medicine through its transcriptome-wide technology, aiming to enhance translational research and clinical diagnostics across various diseases. The company has established partnerships with biopharma leaders and academic institutes to innovate its RNA platform technologies.
Positive
- HTG is advancing precision medicine through innovative transcriptome-wide technology.
- Partnerships with biopharma leaders and institutes enhance HTG's research capabilities.
- Upcoming Q3 financial results and investor call may provide insights into company performance.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was +0.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today announced that it will report its financial results for the third quarter ended September 30, 2021 after the market close on Wednesday, November 10, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30 pm ET.
| Conference Call & Webcast Details | |
| Date: | Wednesday, November 10 |
| Time: | 4:30 pm ET |
| Toll Free: | 877-407-0789 |
| International: | 201-689-8562 |
| Conference ID: | 13723995 |
| Webcast: | https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/46912/indexl.html |
About HTG:
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.
Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.